• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病的细胞起源和病理生理学。

Cellular origin and pathophysiology of chronic lymphocytic leukemia.

机构信息

Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen 45122, Germany.

出版信息

J Exp Med. 2012 Nov 19;209(12):2183-98. doi: 10.1084/jem.20120833. Epub 2012 Oct 22.

DOI:10.1084/jem.20120833
PMID:23091163
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3501361/
Abstract

The cellular origin of chronic lymphocytic leukemia (CLL) is still debated, although this information is critical to understanding its pathogenesis. Transcriptome analyses of CLL and the main normal B cell subsets from human blood and spleen revealed that immunoglobulin variable region (IgV) gene unmutated CLL derives from unmutated mature CD5(+) B cells and mutated CLL derives from a distinct, previously unrecognized CD5(+)CD27(+) post-germinal center B cell subset. Stereotyped V gene rearrangements are enriched among CD5(+) B cells, providing independent evidence for a CD5(+) B cell derivation of CLL. Notably, these CD5(+) B cell populations include oligoclonal expansions already found in young healthy adults, putatively representing an early phase in CLL development before the CLL precursor lesion monoclonal B cell lymphocytosis. Finally, we identified deregulated proteins, including EBF1 and KLF transcription factors, that were not detected in previous comparisons of CLL and conventional B cells.

摘要

慢性淋巴细胞白血病(CLL)的细胞起源仍存在争议,尽管这些信息对于了解其发病机制至关重要。对 CLL 和来自人血液和脾脏的主要正常 B 细胞亚群的转录组分析表明,未突变的免疫球蛋白可变区(IgV)基因 CLL 来源于未突变的成熟 CD5+ B 细胞,而突变的 CLL 来源于一个先前未被识别的、独特的 CD5+CD27+生发中心后 B 细胞亚群。CD5+B 细胞中富含定型的 V 基因重排,为 CLL 的 CD5+B 细胞起源提供了独立的证据。值得注意的是,这些 CD5+B 细胞群体包括已经在年轻健康成年人中发现的寡克隆扩增,推测代表了 CLL 前体病变单克隆 B 细胞淋巴细胞增多之前的早期阶段。最后,我们鉴定到了失调蛋白,包括 EBF1 和 KLF 转录因子,这些蛋白在之前 CLL 与常规 B 细胞的比较中未被检测到。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/40274fd50370/JEM_20120833_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/53c0e0e99d37/JEM_20120833_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/72fb6c3ce5c8/JEM_20120833_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/b2a7c5d0e201/JEM_20120833_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/51fd314cf6ea/JEM_20120833_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/95b3b926643b/JEM_20120833_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/40274fd50370/JEM_20120833_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/53c0e0e99d37/JEM_20120833_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/72fb6c3ce5c8/JEM_20120833_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/b2a7c5d0e201/JEM_20120833_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/51fd314cf6ea/JEM_20120833_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/95b3b926643b/JEM_20120833_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e9/3501361/40274fd50370/JEM_20120833_Fig6.jpg

相似文献

1
Cellular origin and pathophysiology of chronic lymphocytic leukemia.慢性淋巴细胞白血病的细胞起源和病理生理学。
J Exp Med. 2012 Nov 19;209(12):2183-98. doi: 10.1084/jem.20120833. Epub 2012 Oct 22.
2
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach.利用高通量免疫遗传学方法在正常 B 细胞亚群中追踪 CLL 偏向的定型免疫球蛋白基因重排。
Mol Med. 2020 Mar 10;26(1):25. doi: 10.1186/s10020-020-00151-9.
3
Analysis of VH gene expression in CD5+ and CD5- B-cell chronic lymphocytic leukemia.CD5阳性和CD5阴性B细胞慢性淋巴细胞白血病中VH基因表达的分析。
Blood. 1995 Nov 15;86(10):3883-90.
4
New insights into the phenotype and cell derivation of B cell chronic lymphocytic leukemia.B细胞慢性淋巴细胞白血病的表型和细胞起源新见解。
Curr Top Microbiol Immunol. 2005;294:31-49. doi: 10.1007/3-540-29933-5_3.
5
Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.常见B细胞慢性淋巴细胞白血病中使用的VH5基因缺乏广泛突变。
J Exp Med. 1993 Apr 1;177(4):1039-46. doi: 10.1084/jem.177.4.1039.
6
Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis.临床良性CD5阴性单克隆B细胞淋巴细胞增多症中的细胞遗传学异常和免疫球蛋白VH基因突变
Am J Clin Pathol. 2007 Aug;128(2):333-8. doi: 10.1309/WB56ET6AGM44TM5T.
7
New insights into the pathogenesis of chronic lymphocytic leukemia.慢性淋巴细胞白血病发病机制的新见解。
Semin Cancer Biol. 2010 Dec;20(6):377-83. doi: 10.1016/j.semcancer.2010.10.012. Epub 2010 Oct 26.
8
Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes.基于BCL-6和IgV基因突变鉴定B细胞慢性淋巴细胞白血病的三个亚组。
Leukemia. 2000 May;14(5):811-5. doi: 10.1038/sj.leu.2401766.
9
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.IgG+ CD5+ 慢性淋巴细胞白血病B细胞中免疫球蛋白重链和轻链可变区基因的体细胞多样化与选择
J Exp Med. 1995 Apr 1;181(4):1507-17. doi: 10.1084/jem.181.4.1507.
10
Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation.分子单细胞分析显示,健康人类中CD5阳性外周血B细胞的特征是Vkappa基因重排且缺乏体细胞突变。
J Clin Invest. 1997 Oct 1;100(7):1667-76. doi: 10.1172/JCI119691.

引用本文的文献

1
Concurrent Metastatic Clear Cell Renal Cell Carcinoma and Chronic Lymphocytic Leukemia Within the Same Lymph Node: A Case Report and Review of Dual Malignancy Management.同一淋巴结内并发转移性透明细胞肾细胞癌和慢性淋巴细胞白血病:一例报告及双原发恶性肿瘤治疗综述
Cureus. 2025 Jul 7;17(7):e87448. doi: 10.7759/cureus.87448. eCollection 2025 Jul.
2
[Application of next-generation sequencing technology for the investigation of immunoglobulin variable region characteristics and their prognostic significance in patients with chronic lymphocytic leukemia].[应用新一代测序技术研究慢性淋巴细胞白血病患者免疫球蛋白可变区特征及其预后意义]
Zhonghua Xue Ye Xue Za Zhi. 2025 Mar 14;46(3):261-268. doi: 10.3760/cma.j.cn121090-20240819-00310.
3

本文引用的文献

1
FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.FOXO1 是经典霍奇金淋巴瘤中的肿瘤抑制因子。
Blood. 2012 Apr 12;119(15):3503-11. doi: 10.1182/blood-2011-09-381905. Epub 2012 Feb 17.
2
JAB1 is essential for B cell development and germinal center formation and inversely regulates Fas ligand and Bcl6 expression.JAB1 对于 B 细胞发育和生发中心形成是必不可少的,并且可以反向调节 Fas 配体和 Bcl6 的表达。
J Immunol. 2012 Mar 15;188(6):2677-86. doi: 10.4049/jimmunol.1101455. Epub 2012 Feb 10.
3
Early B blasts acquire a capacity for Ig class switch recombination that is lost as they become plasmablasts.
Analysis of Stereotyped B-Cell Receptor Frequencies Among Portuguese De Novo-Diagnosed Chronic Lymphocytic Leukemia Patients (PAIS Study).葡萄牙初诊慢性淋巴细胞白血病患者中定型B细胞受体频率分析(PAIS研究)
Cancers (Basel). 2025 Apr 14;17(8):1316. doi: 10.3390/cancers17081316.
4
Identification, assembly and characterization of tumor immunoglobulin transcripts from RNA sequencing data using IgSeqR.使用IgSeqR从RNA测序数据中鉴定、组装和表征肿瘤免疫球蛋白转录本。
Nat Protoc. 2025 Apr 24. doi: 10.1038/s41596-025-01172-6.
5
Enhanced interpretation of immune cell phenotype and function through a rhesus macaque single-cell atlas.通过恒河猴单细胞图谱增强对免疫细胞表型和功能的解读。
Cell Genom. 2025 May 14;5(5):100849. doi: 10.1016/j.xgen.2025.100849. Epub 2025 Apr 14.
6
Insights into the transcriptional regulation of CD22 in B cell chronic lymphocytic leukemia.B细胞慢性淋巴细胞白血病中CD22转录调控的研究进展
J Biol Chem. 2025 Apr;301(4):108386. doi: 10.1016/j.jbc.2025.108386. Epub 2025 Mar 5.
7
Insights into genetic aberrations and signalling pathway interactions in chronic lymphocytic leukemia: from pathogenesis to treatment strategies.慢性淋巴细胞白血病中基因畸变与信号通路相互作用的见解:从发病机制到治疗策略
Biomark Res. 2024 Dec 28;12(1):162. doi: 10.1186/s40364-024-00710-w.
8
B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.B 细胞分化与人类 B 细胞淋巴瘤的起源和发病机制。
Methods Mol Biol. 2025;2865:1-30. doi: 10.1007/978-1-0716-4188-0_1.
9
B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformation.B 细胞内在的 RANK 信号与 TCL1 协同作用诱导谱系依赖性 B 细胞转化。
Blood Cancer J. 2024 Aug 28;14(1):151. doi: 10.1038/s41408-024-01123-6.
10
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.T 细胞转录因子抑制慢性淋巴细胞白血病恶性 B 细胞增殖。
Blood. 2024 Aug 1;144(5):510-524. doi: 10.1182/blood.2023021990.
早期 B 细胞获得了免疫球蛋白类别转换重组的能力,而当它们成为浆母细胞时,这种能力就会丧失。
Eur J Immunol. 2011 Dec;41(12):3506-12. doi: 10.1002/eji.201141762. Epub 2011 Nov 10.
4
FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling.FcRL4 作为一种适应性先天分子开关,可抑制 BCR 信号转导并增强 TLR 信号转导。
Blood. 2011 Dec 8;118(24):6332-41. doi: 10.1182/blood-2011-05-353102. Epub 2011 Sep 8.
5
Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC.BCL6 在 pre-B 细胞受体介导的激活作用下,通过转录抑制 MYC 诱导 pre-B 细胞静止。
Blood. 2011 Oct 13;118(15):4174-8. doi: 10.1182/blood-2011-01-331181. Epub 2011 Aug 19.
6
Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.自我更新的造血干细胞是人类慢性淋巴细胞白血病发病机制中的主要靶点。
Cancer Cell. 2011 Aug 16;20(2):246-59. doi: 10.1016/j.ccr.2011.06.029.
7
Activation-induced cytidine deaminase mediates central tolerance in B cells.激活诱导胞苷脱氨酶在 B 细胞中介导中枢耐受。
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11560-5. doi: 10.1073/pnas.1102571108. Epub 2011 Jun 23.
8
Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans.激活诱导胞嘧啶脱氨酶 (AID) 对于人类 B 细胞耐受是必需的。
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11554-9. doi: 10.1073/pnas.1102600108. Epub 2011 Jun 23.
9
Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.核过表达淋巴增强结合因子 1 可识别小 B 细胞淋巴瘤中的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤。
Mod Pathol. 2011 Nov;24(11):1433-43. doi: 10.1038/modpathol.2011.103. Epub 2011 Jun 17.
10
Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-.人脐带和成人外周血中的 B1 细胞表达新型表型 CD20+ CD27+ CD43+ CD70-。
J Exp Med. 2011 Jan 17;208(1):67-80. doi: 10.1084/jem.20101499. Epub 2011 Jan 10.